Artificial Organs (LEBAO) of Hannover Medical School (MHH) and deputy coordinator of the REBIRTH (From Regenerative Biology to Reconstructive Therapy) cluster of excellence, as well as Professor Dr. Ilan Marek

Hannover. The main foci of the meeting include gene therapy, cell therapy, stem cell biology and regenerative medicine. Approx. 1,000 international participants are expected to attend in order to discuss

yet acquired many mutations, therefore, representing an ideal cell source for patient-specific regenerative therapies. On October 27, 2010, the Society of the Friends of Hannover Medical School (GdF) e

profile Zhong Huang M.D., PhD Postdoctoral Researcher, iPSC-derived peripheral nerve organoids for regenerative tissue transplantation +49(0)511 532 2911 Huang.Zhong @ mh-hannover.de Expert profile

regularly traveled to Baden-Württemberg. The secretary at the REBIRTH Center for Translational Regenerative Medicine cares for her 98-year-old father near Stuttgart. “He lives at home but is quite frail

[“Molecular Medicine”, “Infection Biology”(& DEWIN: Dynamik der Erreger-Wirt Interaktionen), “Regenerative Sciences”, "Auditory Sciences", "Epidemiology" and "BIOMEDAS - Biomedical Data Sciences"]. There

Project leaders: Daphne DeTemple / Stefan Kalies (NIFE) The liver is known to possess extensive regenerative capabilities, the processes and pathways of which are not fully understood. In order to gain a

tool for the development of new therapies, for example to repair damaged hearts with the help of regenerative medicine. How the many different cell types develop step by step during heart development and

close collaborations with other projects within the MHH and the Research Center for Translational Regenerative Medicine REBIRTH as well as with the Competence Center for Cardiovascular Implants (Medimplant)

of iPS cells. To guarantee the safety of potential future clinical applications of iPSC-based regenerative cell therapies, we improve our manufacturing protocols for GMP-compatible iPS cell products c [...] heart or the respiratory tract, are associated with genetic defects or mutations. In principle, regenerative therapies are conceivable, in which patient-specific cells are obtained, reprogrammed into iPS [...] optimized for their use in organotypic disease models and screening systems, as well as in cell-based regenerative therapies. Even though extensive information about developmental biology is already accessible